Lee, Danner & Bass’s Avanos Medical AVNS Stock Holding History

Lee, Danner & Bass’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13	Closed	-$207	–	256
2024 Q4	$207	Buy	+13	New	+$257	﹤0.01%	739

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lee, Danner & Bass's AVNS Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 13 shares — an estimated $207 sold.

Lee, Danner & Bass first reported a position in AVNS in Q4 2024 and held it in 1 quarter. The position peaked at $207 in Q4 2024. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

Lee, Danner & Bass reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 13 Avanos Medical shares in Q1 2025, an estimated $207.
Lee, Danner & Bass first reported a position in Avanos Medical in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's Avanos Medical position peaked at $207 in Q4 2024.
277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.